Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Ri

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2022
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assayShinya Hagiwara, Shigeru Kusumoto, Takako Inoue, et al.
Leukemia Research|October 3, 2012
Angioimmunoblastic T-cell lymphoma mice modelFumihiko Sato, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Volunteer unrelated donor cell-derived acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Shinya Hagiwara, Shigeru Kusumoto, Asahi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Journal of Human Genetics|October 19, 2025
Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphomaShimon Nakashima, Masataka Nakano, Tatsuki Fukami, et al.
British Journal of Haematology|April 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphomaTomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, et al.
British Journal of Haematology|April 26, 2017
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myelomaShotaro Tatekawa, Yoshiaki Chinen, Masaki Ri, et al.
Cancer Research|October 2, 2014
Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myelomaYoshiaki Chinen, Junya Kuroda, Yuji Shimura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2022
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assayShinya Hagiwara, Shigeru Kusumoto, Takako Inoue, et al.
Leukemia Research|October 3, 2012
Angioimmunoblastic T-cell lymphoma mice modelFumihiko Sato, Takashi Ishida, Asahi Ito, et al.
Ejhaem|July 18, 2022
Volunteer unrelated donor cell-derived acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Shinya Hagiwara, Shigeru Kusumoto, Asahi Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.
International Journal of Oncology|December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cellsNaoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Journal of Human Genetics|October 19, 2025
Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphomaShimon Nakashima, Masataka Nakano, Tatsuki Fukami, et al.
British Journal of Haematology|April 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphomaTomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga, et al.
British Journal of Haematology|April 26, 2017
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myelomaShotaro Tatekawa, Yoshiaki Chinen, Masaki Ri, et al.
Cancer Research|October 2, 2014
Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myelomaYoshiaki Chinen, Junya Kuroda, Yuji Shimura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantationTomoko Narita, Takashi Ishida, Ayako Masaki, et al.
Pageof 12